Literature DB >> 14657095

Reversible dilated cardiomyopathy related to amphotericin B therapy.

Patrick J Danaher1, Michael K Cao, Gregory M Anstead, Matthew J Dolan, Caroline C DeWitt.   

Abstract

We describe a patient who developed dilated cardiomyopathy and clinical congestive heart failure after 2 months of therapy with amphotericin B (AmB) for disseminated coccidioidomycosis. His echocardiographic abnormalities and heart failure resolved after posaconazole was substituted for AmB. It is important to recognize the rare and potentially reversible toxicity of AmB.

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14657095     DOI： 10.1093/jac/dkg472

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


  7 in total

Review 1.  Heart failure induced by non-cardiac drugs.

Authors:  Lars Slørdal; Olav Spigset
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

2.  Hypothyroidism Presenting as Dilated Cardiomyopathy.

Authors:  R Bhardwaj
Journal:  Med J Armed Forces India       Date:  2011-07-21

3.  Recovery and recurrence of left ventricular systolic dysfunction in patients with idiopathic dilated cardiomyopathy.

Authors:  Jeonggeun Moon; Young-Guk Ko; Namsik Chung; Jong-Won Ha; Seok-Min Kang; Eui-Young Choi; Se-Joong Rim
Journal:  Can J Cardiol       Date:  2009-05       Impact factor: 5.223

Review 4.  Cardiac imaging approaches to evaluate drug-induced myocardial dysfunction.

Authors:  Jennifer B Christian; John K Finkle; Bonnie Ky; Pamela S Douglas; David E Gutstein; Paul D Hockings; Pierre Lainee; Daniel J Lenihan; Jay W Mason; Philip T Sager; Thomas G Todaro; Karen A Hicks; Robert C Kane; Hon-Sum Ko; JoAnn Lindenfeld; Eric L Michelson; James Milligan; Jiefen Y Munley; Joel S Raichlen; Amir Shahlaee; Colette Strnadova; Brenda Ye; J Rick Turner
Journal:  Am Heart J       Date:  2012-10-26       Impact factor: 4.749

5.  Amphotericin B-gum arabic conjugates: synthesis, toxicity, bioavailability, and activities against Leishmania and fungi.

Authors:  K K Nishi; M Antony; P V Mohanan; T V Anilkumar; P M Loiseau; A Jayakrishnan
Journal:  Pharm Res       Date:  2007-03-20       Impact factor: 4.580

6.  Reversible cardiomyopathy secondary to Amphotericin-B.

Authors:  Antonio Carlos Bandeira; José Magalhães Filho; Karine de Almeida Ramos
Journal:  Med Mycol Case Rep       Date:  2016-10-06

Review 7.  Sixty years of Amphotericin B: An Overview of the Main Antifungal Agent Used to Treat Invasive Fungal Infections.

Authors:  Francelise B Cavassin; João Luiz Baú-Carneiro; Rogério R Vilas-Boas; Flávio Queiroz-Telles
Journal:  Infect Dis Ther       Date:  2021-02-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.